Allergan, Inc - AGN- Profile

Allergan, Inc.. The Group's principal activity is to develop and commercialize specialty pharmaceutical products for the ophthalmic, neurological, dermatological and other specialty markets. It also performs pharmaceutical research, targeting products and technologies related to specific diseases such as glaucoma, retinal disease, dry eye, psoriasis, acne and movement disorders. The Group also develops and markets aesthetic-related pharmaceuticals and over-the-counter products. The Group operates mainly in the United States, Europe, Latin America and Asia Pacific.In Mar 2006, The Group completed the acquisition of Inamed Corporation. Specialty pharmaceuticals accounted for 86% of 2006 revenues; Medical devices, 12%& Other, 2%